Pathobiology · 1998 · 15 citations · 19 references
MedicineGeneticsPathologyCancer GeneticsMolecular OncologyNeoplasiaCervical CancerCervical Intraepithelial NeoplasiaCervical LesionsCervical PathologyLoss Of HeterozygositySquamous Cell CarcinomaCervical Intraepithelial Neoplasia 3Cervical Intraepithelial Neoplasia GradingCervical Tumor GradingChromosome 3P LossInvasive Cervical CarcinomaMicroinvasive Cervical CarcinomaMicrosatellite Instability AnalysisMicrosatellite Markers
Losses of heterozygosity on the short arm of chromosome 3p are common in cervical carcinomas in the 3p13-3p21 region, and can be observed in intra-epithelial lesions accompanying cervical cancers. As a preliminary attempt to determine whether these losses can be observed in intra-epithelial cervical lesions without concomitant invasive carcinoma, we have used two microsatellite markers located at the two most frequently deleted segments of the 3p13-3p21 region. We have studied 36 cases of grade II and grade III cervical intra-epithelial neoplasias obtained by conisation biopsies and 30 cases of cervical carcinoma including 3 micro-invasive squamous cell carcinomas. We found loss of heterozygosity or microsatellite instability in 6 of 16 (38%) and 9 of 23 (39%) informative cases of cervical carcinoma at 3p13 and 3p21, respectively. Four of 27 (15%) cases of cervical intra-epithelial neoplasia showed loss of heterozygosity at 3p13, whereas loss of heterozygosity or microsatellite instability at 3p21 was found in 5 of 19 cases (26%). No relationship was found between 3p loss of heterozygosity and human papillomavirus infection. In conclusion, losses of heterozygosity at 3p13 and 3p21 occur in premalignant lesions without concomitant invasive lesions. The prevalence and precise extent of these losses should be established by a more extensive analysis.
19
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Randall K. Saiki, David H. Gelfand, Susanne Stoffel et al. · Science · 1988 · 17.2K citations
Allelotype of human ovarian cancer.
Takaaki Sato, Hiroko Saito, Ryoji Morita et al. · PubMed · 1991 · 256 citations
Life Sciences, Genetics, Oncology +17
Marc Baay, W G Quint, J Koudstaal et al. · Journal of Clinical Microbiology · 1996 · 244 citations · Full text